Back
Immix Biopharma, Inc. Stock Predictions
When an AI Platform Gets Pulled by Too Much Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
56
IMMX
Immix Biopharma, Inc.
Last Price:
$6.75
Seasonality Move:
-38.58%
7 Day Trial
ALL ACCESS PASS
$
7
As AI Startups Cool, One Marketing Company Is Spinning Off Winners
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiImmix Biopharma, Inc. Stock Forecast
-
Over the next 52 weeks, Immix Biopharma, Inc. has on average historically risen by 48.8% based on the past 4 years of stock performance.
-
Immix Biopharma, Inc. has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Immix Biopharma, Inc. Stock Undervalued?The current Immix Biopharma, Inc. [IMMX] share price is $6.74. The Score for IMMX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
IMMX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Immix Biopharma, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Immix Biopharma, Inc. has on average historically risen by 48.8% based on the past 4 years of stock performance.
Immix Biopharma, Inc. Stock Rating
Buy
56
Immix Biopharma, Inc. (IMMX)
is a Buy
Is Immix Biopharma, Inc. overpriced?
-
Immix Biopharma, Inc. has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Immix Biopharma, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immixbio.com
52-Week Data
52-Week High:
7.73
52-Week Low:
1.34
Prediction Charts
Market Cap:
226.3M
Price in USD:
6.74
Volume:
867.2K
Beta:
0.32
Technical Analysis
SMA50:
5.39
SMA100:
4.14
SMA200:
3.22
52-Wk Change:
233.66%
Stock Predictions
-
Is Immix Biopharma, Inc. stock public?Yes, Immix Biopharma, Inc. is a publicly traded company.
-
What is the Immix Biopharma, Inc. stock quote today?The Immix Biopharma, Inc. stock price is 6.74 USD today.
-
How to buy Immix Biopharma, Inc. stock online?You can buy Immix Biopharma, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-20 | 4.60 | 4.60 | 4.83 | 4.54 |
| Jan-21 | 4.62 | 4.89 | 5.02 | 4.55 |
| Jan-22 | 4.90 | 5.25 | 5.28 | 4.89 |
| Jan-23 | 5.25 | 5.38 | 5.52 | 5.07 |
| Jan-26 | 5.35 | 5.39 | 5.45 | 5.07 |
| Jan-27 | 5.40 | 5.94 | 5.98 | 5.40 |
| Jan-28 | 6.05 | 6.14 | 6.33 | 5.82 |
| Jan-29 | 6.23 | 5.95 | 6.27 | 5.61 |
| Jan-30 | 5.87 | 5.83 | 6.20 | 5.75 |
| Feb-2 | 5.76 | 6.21 | 6.35 | 5.73 |
| Feb-3 | 6.21 | 6.36 | 6.49 | 5.99 |
| Feb-4 | 6.31 | 6.12 | 6.34 | 5.91 |
| Feb-5 | 5.99 | 5.95 | 6.52 | 5.89 |
| Feb-6 | 6.09 | 6.74 | 6.87 | 6.06 |
Immix Biopharma, Inc. Earnings
Immix Biopharma, Inc. Earnings Report: Per Share Immix Biopharma, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Immix Biopharma, Inc. Forecast Revenue Growth
Immix Biopharma, Inc. Stock Analysis: Historical quarterly revenues per share for Immix Biopharma, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.00 per share.
* Immix Biopharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.